Anti-VEGF therapy improves outcomes in retinal diseases by targeting neovascularization and macular edema, crucial in conditions like AMD and diabetic retinopathy. Optical coherence tomography is ...

Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating age-related macular degeneration (AMD) fail in some patients. Using that ...

Please provide your email address to receive an email when new articles are posted on . Continuous growth of macular neovascularization size, as well as development of outer retina atrophy, was ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) regulates abnormal blood vessel growth in the damaged retina, which ...

Eye drop nanoparticles that shrink over time overcome the eye's natural defenses, delivering protein drugs to the retina and ...

Please provide your email address to receive an email when new articles are posted on . Patients with inherited retinal diseases may present with seemingly routine conditions. Look for comorbid ...

Branch retinal vein occlusion (BRVO) is when a blockage forms in the veins branching off the retina, which can disrupt blood flow. Treatment depends on the type of blockage and severity of the damage.

Manufacturing differences between ranibizumab and aflibercept biosimilars might shape pricing, uptake, and patient access globally.

Retinal vein occlusion (RVO) is one of the leading causes of vision loss worldwide, often triggered by chronic diseases such as hypertension and diabetes. Similar to a blocked water pipe causing ...

An mRNA vaccine suppressed neovascularization—a condition caused by age-related macular degeneration (AMD), a leading cause of vision loss for elderly people—in the retina of mouse models. The vaccine ...